GovChime
AWARDBPA CALLOther than small business

BPA call 75F40121F19005DELOITTE CONSULTING LLP

Overview

Award facts

Net obligations
$86.14M
$86,143,930of $86.14M potential value
Outlays (paid to date)
$83.64M
$83.64M paid of $86.14M obligated$83,635,962
Period of performance
Jul 14, 2021 to Jul 12, 2024
Ended
Modifications
9
Latest action Feb 4, 2026
Contract type
BPA call
PIID 75F40121F19005

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

CBER SYSTEMS AND MODERNIZATION BPA TASK ORDER 6

Dates and value

Award date
Signed on Jul 14, 2021
Potential end of performance
Jul 11, 2024
Current value
$86,143,930Base and exercised options
Potential value (if all options are exercised)
$86,143,930
Parent contract vehicle
HHSF223201700019B (BPA, single award) — 6 orders recorded under it

Obligations by fiscal year of action

  • FY2026: -$3,189,573 (de-obligation)
  • FY2024: $21,281,389
  • FY2023: $23,924,107
  • FY2022: $25,393,607
  • FY2021: $18,734,400

Total across 5 fiscal years: $86,143,930

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Feb 4, 2026. View on USAspending · Recipient on SAM.gov

Recipient

NameDELOITTE CONSULTING LLP
LocationARLINGTON, VA
UEICKV2L9GZKJK3
CAGE code1TTG5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership
Parent companyDELOITTE CONSULTING LLP

Business types and certifications

For-profit organizationPartnership or LLP

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Cures activities; Direct program activity; Biologics; Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600, 075-0945, 075-5629Federal accounts (agency financial reports)

Place of performance

Place of performance
Arlington, Virginia 22209-1742
Congressional district (place of performance)
VA-08As reported at the time of the action

Classification and competition

Classification

NAICS
541512COMPUTER SYSTEMS DESIGN SERVICES
Product or service (PSC)
DD01IT AND TELECOM - SERVICE DELIVERY SUPPORT SERVICES: ITSM, OPERATIONS CENTER, PROJECT/PM (LABOR) (service)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Firm fixed priceJ

Contract details

Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Transaction history

Modification history

Base award
Jul 14, 2021Base obligation at award: $18,495,545
Latest action
Feb 4, 2026 — CloseoutModification P00009; obligation change -$3,189,573; administrative: no change in scope or value
Latest substantive action
Dec 11, 2023 — Change orderModification P00008; obligation change +$21,281,389
Latest funding action
Sep 20, 2021 — Funding onlyModification P00001; obligation change +$238,855; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Supplemental agreement (within scope)4
  • Change order3
  • Funding only1
  • Closeout1
10 actions recorded, Jul 14, 2021 to Feb 4, 2026; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$3,189,573
Latest action: change in base and all options
-$3,189,573

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
Yes

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
BPA callA
Parent vehicle type
BPAE
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
10

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2021/2021-0600-000
  • 075-2022/2022-0600-000
  • 075-2023/2023-0600-000
  • 075-2024/2024-0600-000
  • 075-X-0600-000
  • 075-X-0945-000
Show all 7 accounts
  • 075-X-5629-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.7: Operation and maintenance of equipment
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$3,388,855
COVID-19 supplemental outlays
$3,388,855